Anti-apoptotic effect of HIV protease inhibitors via direct inhibition of calpain

被引:29
作者
Ghibelli, L
Mengoni, F
Lichtner, M
Coppola, S
De Nicola, M
Bergamaschi, A
Mastroianni, C
Vullo, V
机构
[1] Univ Roma Tor Vergata, Dipartimento Biol, I-00133 Rome, Italy
[2] Univ Roma La Sapienza, Dipartimento Malattie Infett, Rome, Italy
[3] Univ Roma Tor Vergata, Cattedra Med Lavoro, I-00133 Rome, Italy
关键词
HIV; protease inhibitors; indinavir; apoptosis; calpain; caspases;
D O I
10.1016/S0006-2952(03)00505-7
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Treatment with drugs designed to inhibit the HIV protease ameliorates immune functions in AIDS patients, reducing cell deletion by apoptosis even in the absence of inhibition of viral spread. This suggests that they interact with the intrinsic apoptotic signaling. We found that caspases. the main executioner of the apoptotic process, are not directly inhibited. In search for the mechanism responsible for their anti-apoptotic effect, we have found that indinavir and ritonavir are able to inhibit apoptosis only in those cell systems where apoptosis involves the activation of calpains. They directly inhibit a calpain-like activity expressed in lysates from apoptotic cells, to the same extent as commercially available calpain inhibitor 1. In in vitro assays with purified calpains, indinavir and ritonavir strongly inhibit m-calpain, and moderately p-calpain. These results have great therapeutic implications, going beyond AIDS treatment, since many degenerative disorders involve abnormal calpain activation, indicating calpain as an ideal pharmacological target. Indinavir and ritonavir, potent m-calpain inhibitors, largely used since several years on humans without important negative side effects, may become powerful tools against those pathologies. (C) 2003 Published by Elsevier Inc.
引用
收藏
页码:1505 / 1512
页数:8
相关论文
共 34 条
[1]   Mechanisms of HIV-associated lymphocyte apoptosis [J].
Badley, AD ;
Pilon, AA ;
Landay, A ;
Lynch, DH .
BLOOD, 2000, 96 (09) :2951-2964
[2]   Dynamic correlation of apoptosis and immune activation during treatment of HIV infection [J].
Badley, AD ;
Parato, K ;
Cameron, DW ;
Kravcik, S ;
Phenix, BN ;
Ashby, D ;
Kumar, A ;
Lynch, DH ;
Tschopp, J ;
Angel, JB .
CELL DEATH AND DIFFERENTIATION, 1999, 6 (05) :420-432
[3]   Synergistic activation of caspase-3 by m-calpain after neonatal hypoxia-ischemia - A mechanism of "pathological apoptosis"? [J].
Blomgren, K ;
Zhu, CL ;
Wang, XY ;
Karlsson, JO ;
Leverin, AL ;
Bahr, BA ;
Mallard, C ;
Hagberg, H .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (13) :10191-10198
[4]  
Chan SL, 1999, J NEUROSCI RES, V58, P167, DOI 10.1002/(SICI)1097-4547(19991001)58:1<167::AID-JNR16>3.3.CO
[5]  
2-B
[6]   Initiator caspases in apoptosis signaling pathways [J].
Chen, M ;
Wang, J .
APOPTOSIS, 2002, 7 (04) :313-319
[7]   GSH extrusion and the mitochondrial pathway of apoptotic signalling [J].
Coppola, S ;
Ghibelli, L .
BIOCHEMICAL SOCIETY TRANSACTIONS, 2000, 28 :56-61
[8]   HIV-protease inhibitors [J].
Flexner, C .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (18) :1281-1292
[9]  
Gao G, 2000, J CELL BIOCHEM, V80, P53
[10]   Glutathione depletion causes cytochrome c release even in the absence of cell commitment to apoptosis [J].
Ghibelli, L ;
Coppola, S ;
Fanelli, C ;
Rotilio, G ;
Civitareale, P ;
Scovassi, AI ;
Ciriolo, MR .
FASEB JOURNAL, 1999, 13 (14) :2031-2036